A Drug Is Credited With Slight Gains for Patients Who Have Lung Cancer
May 31st, 2008 by
The drug Erbitux lengthened the survival of patients with advanced lung cancer by about five weeks, researchers have reported.
Posted in ImClone Systems Incorporated|IMCL|NASDAQ, Lungs, Erbitux (Drug), Cancer, Chicago (Ill)